Perindopril/Indapamide 2/0.625 mg/day: A Review of its Place in the Management of Hypertension

Author： Matheson A.J.   Cheer S.M.   Goa K.L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.8, 2001-01, pp. : 1211-1229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?

By Waeber Bernard  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2291-2299

Informa Healthcare

Access to resources Recommend Favorite

Perindopril: An Updated Review of Its Use in Hypertension

By Hurst M.   Jarvis B.  

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 867-896

Adis International

Access to resources Recommend Favorite

BP lowering with perindopril/indapamide an ADVANCE in diabetes

By  

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Gender influences BP response to perindopril/indapamide

By  

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Perindopril/Indapamide: A Viewpoint by Norman M. Kaplan

By Kaplan N.M.  

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 303-304

Adis International

Access to resources Recommend Favorite